ENvue Medical, Inc. also files under NAOV; those filings are included. Filings under FEED by AgFeed Industries, Inc. (CIK 0001331427) from Sep 25, 2008 to Mar 1, 2013 belong to a different issuer and are not shown.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Apr 15, 2026 | Glibert Christian Michael | Insider | Other(J) | 0 | — | $0 |
| Feb 2, 2026 | Bank Of America Corp | 10% Owner | Sell(S) | 50 | $3.05 | $153 |
| Feb 2, 2026 | Bank Of America Corp | 10% Owner | Sell(S) | 50 | $3.05 | $153 |
| Feb 2, 2026 | Bank Of America Corp | 10% Owner | Sell(S) | 100 | $3.05 | $305 |
| Feb 2, 2026 | Bank Of America Corp | 10% Owner | Sell(S) | 100 | $3.05 | $305 |
| Feb 2, 2026 | Bank Of America Corp | 10% Owner | Sell(S) | 183 | $3.05 | $558 |
| Feb 2, 2026 | Bank Of America Corp | 10% Owner | Sell(S) | 2 | $3.05 | $6 |
| Feb 2, 2026 | Bank Of America Corp | 10% Owner | Sell(S) | 50 | $3.05 | $153 |
| Feb 2, 2026 | Bank Of America Corp | 10% Owner | Sell(S) | 417 | $3.05 | $1K |
| Feb 2, 2026 | Bank Of America Corp | 10% Owner | Sell(S) | 98 | $3.05 | $299 |
| Feb 2, 2026 | Bank Of America Corp | 10% Owner | Sell(S) | 50 | $3.05 | $153 |
| Feb 2, 2026 | Bank Of America Corp | 10% Owner | Sell(S) | 100 | $3.06 | $306 |
| Feb 2, 2026 | Bank Of America Corp | 10% Owner | Sell(S) | 50 | $3.05 | $153 |
| Feb 2, 2026 | Bank Of America Corp | 10% Owner | Sell(S) | 100 | $3.07 | $307 |
| Feb 2, 2026 | Bank Of America Corp | 10% Owner | Sell(S) | 90 | $3.05 | $275 |
| Feb 2, 2026 | Bank Of America Corp | 10% Owner | Sell(S) | 10 | $3.05 | $31 |
| Feb 2, 2026 | Bank Of America Corp | 10% Owner | Sell(S) | 100 | $3.07 | $307 |
| Feb 2, 2026 | Bank Of America Corp | 10% Owner | Sell(S) | 100 | $3.05 | $305 |
| Feb 2, 2026 | Bank Of America Corp | 10% Owner | Sell(S) | 18 | $3.05 | $55 |
| Feb 2, 2026 | Bank Of America Corp | 10% Owner | Sell(S) | 50 | $3.05 | $153 |
| Feb 2, 2026 | Bank Of America Corp | 10% Owner | Sell(S) | 50 | $3.05 | $153 |
| Feb 2, 2026 | Bank Of America Corp | 10% Owner | Sell(S) | 50 | $3.05 | $153 |
| Feb 2, 2026 | Bank Of America Corp | 10% Owner | Sell(S) | 500 | $3.05 | $2K |
| Feb 2, 2026 | Bank Of America Corp | 10% Owner | Sell(S) | 200 | $3.06 | $612 |
| Feb 2, 2026 | Bank Of America Corp | 10% Owner | Sell(S) | 100 | $3.04 | $304 |
| Feb 2, 2026 | Bank Of America Corp | 10% Owner | Sell(S) | 4 | $3.05 | $12 |
| Feb 2, 2026 | Bank Of America Corp | 10% Owner | Sell(S) | 4 | $3.05 | $12 |
| Feb 2, 2026 | Bank Of America Corp | 10% Owner | Sell(S) | 10 | $3.05 | $31 |
| Feb 2, 2026 | Bank Of America Corp | 10% Owner | Sell(S) | 100 | $3.05 | $305 |
| Feb 2, 2026 | Bank Of America Corp | 10% Owner | Sell(S) | 82 | $3.05 | $250 |
| Feb 2, 2026 | Bank Of America Corp | 10% Owner | Sell(S) | 100 | $3.05 | $305 |
| Jan 14, 2026 | Glibert Christian Michael | 10% Owner | Buy(P) | 240K | $2.67 | $641K |
| Dec 30, 2024 | Fashek Christopher M | Director | Grant(A) | 50K | — | $0 |
| Dec 30, 2024 | Jacob Harold | Chief Medical Officer, Director | Grant(A) | 10K | — | $0 |
| Dec 30, 2024 | Ferguson Michael | Director | Grant(A) | 20K | — | $0 |
| Dec 30, 2024 | Goldstein Martin M | Director | Grant(A) | 23K | — | $0 |
| Dec 30, 2024 | Schroeder Maria | Director | Grant(A) | 20K | — | $0 |
| Dec 30, 2024 | Brown Stephen Russell | Chief Financial Officer | Grant(A) | 50K | — | $0 |
| Dec 30, 2024 | Mika Thomas | Director | Grant(A) | 20K | — | $0 |
| Dec 30, 2024 | Cassirer Aurora | Director | Grant(A) | 20K | — | $0 |
| Dec 30, 2024 | Murphy Brian M | Chief Executive Officer, Director | Grant(A) | 80K | — | $0 |
| Jan 23, 2024 | Goldstein Martin M | Director | Grant(A) | 17K | — | $0 |
| Jan 23, 2024 | Ferguson Michael | Director | Grant(A) | 17K | — | $0 |
| Jan 23, 2024 | Schroeder Maria | Director | Grant(A) | 17K | — | $0 |
| Jan 23, 2024 | Jacob Harold | Chief Medical Officer, Director | Grant(A) | 7K | — | $0 |
| Jan 23, 2024 | Mika Thomas | Director | Grant(A) | 17K | — | $0 |
| Jan 23, 2024 | Cassirer Aurora | Director | Grant(A) | 17K | — | $0 |
| Nov 29, 2023 | Ferguson Michael | Director | Disposed to issuer(D) | 4K | — | $0 |
| Nov 29, 2023 | Schroeder Maria | Director | Disposed to issuer(D) | 3K | — | $0 |
| Nov 29, 2023 | Mika Thomas | Director | Disposed to issuer(D) | 2K | — | $0 |
| Nov 29, 2023 | Mika Thomas | Director | Disposed to issuer(D) | 2K | — | $0 |
| Nov 29, 2023 | Mika Thomas | Director | Disposed to issuer(D) | 3K | — | $0 |
| Nov 29, 2023 | Mika Thomas | Director | Disposed to issuer(D) | 5K | — | $0 |
| Nov 29, 2023 | Mika Thomas | Director | Disposed to issuer(D) | 3K | — | $0 |
| Nov 29, 2023 | Jacob Harold | Chief Medical Officer, Director | Disposed to issuer(D) | 3K | — | $0 |
| Nov 29, 2023 | Jacob Harold | Chief Medical Officer, Director | Disposed to issuer(D) | 3K | — | $0 |
| Nov 29, 2023 | Ferguson Michael | Director | Disposed to issuer(D) | 3K | — | $0 |
| Nov 29, 2023 | Ferguson Michael | Director | Disposed to issuer(D) | 3K | — | $0 |
| Nov 29, 2023 | Ferguson Michael | Director | Disposed to issuer(D) | 2K | — | $0 |
| Nov 29, 2023 | Cassirer Aurora | Director | Disposed to issuer(D) | 3K | — | $0 |
| Nov 29, 2023 | Brown Stephen Russell | Chief Financial Officer | Disposed to issuer(D) | 563 | — | $0 |
| Nov 29, 2023 | Brown Stephen Russell | Chief Financial Officer | Disposed to issuer(D) | 3K | — | $0 |
| Nov 29, 2023 | Brown Stephen Russell | Chief Financial Officer | Disposed to issuer(D) | 3K | — | $0 |
| Nov 29, 2023 | Brown Stephen Russell | Chief Financial Officer | Disposed to issuer(D) | 5K | — | $0 |
| Nov 29, 2023 | Goldstein Martin M | Director | Disposed to issuer(D) | 3K | — | $0 |
| Nov 29, 2023 | Goldstein Martin M | Director | Disposed to issuer(D) | 3K | — | $0 |
| Nov 29, 2023 | Goldstein Martin M | Director | Disposed to issuer(D) | 3K | — | $0 |
| Nov 29, 2023 | Goldstein Martin M | Director | Disposed to issuer(D) | 2K | — | $0 |
| Nov 29, 2023 | Goldstein Martin M | Director | Disposed to issuer(D) | 1K | — | $0 |
| Nov 29, 2023 | Goldstein Martin M | Director | Disposed to issuer(D) | 5K | — | $0 |
| Nov 29, 2023 | Fashek Christopher M | Director | Disposed to issuer(D) | 2K | — | $0 |
| Nov 29, 2023 | Fashek Christopher M | Director | Disposed to issuer(D) | 4K | — | $0 |
| Nov 29, 2023 | Fashek Christopher M | Director | Disposed to issuer(D) | 6K | — | $0 |
| Nov 29, 2023 | Fashek Christopher M | Director | Disposed to issuer(D) | 3K | — | $0 |
| Nov 29, 2023 | Fashek Christopher M | Director | Disposed to issuer(D) | 1K | — | $0 |
| Nov 29, 2023 | Murphy Brian M | Chief Executive Officer, Director | Disposed to issuer(D) | 2K | — | $0 |
| Nov 29, 2023 | Murphy Brian M | Chief Executive Officer, Director | Disposed to issuer(D) | 3K | — | $0 |
| Nov 29, 2023 | Murphy Brian M | Chief Executive Officer, Director | Disposed to issuer(D) | 15K | — | $0 |
| Nov 29, 2023 | Murphy Brian M | Chief Executive Officer, Director | Disposed to issuer(D) | 10K | — | $0 |
| Nov 15, 2023 | Goldstein Martin M | Director | Grant(A) | 3K | — | $0 |
| Nov 15, 2023 | Fashek Christopher M | Director | Grant(A) | 14K | — | $0 |
| Nov 15, 2023 | Murphy Brian M | Chief Executive Officer, Director | Grant(A) | 20K | — | $0 |
| Nov 15, 2023 | Brown Stephen Russell | Chief Financial Officer | Grant(A) | 14K | — | $0 |
| Nov 15, 2023 | Schroeder Maria | Director | Grant(A) | 3K | — | $0 |
| Nov 15, 2023 | Cassirer Aurora | Director | Grant(A) | 3K | — | $0 |
| Nov 15, 2023 | Ferguson Michael | Director | Grant(A) | 3K | — | $0 |
| Nov 15, 2023 | Mika Thomas | Director | Grant(A) | 3K | — | $0 |
| Nov 15, 2023 | Jacob Harold | Chief Medical Officer, Director | Grant(A) | 3K | — | $0 |
| Jan 5, 2023 | Mika Thomas | Director | Buy(P) | 50K | $0.25 | $13K |
| Jun 15, 2022 | Fashek Christopher M | Director | Buy(P) | 40K | $0.60 | $24K |
| Jun 14, 2022 | Brown Stephen Russell | Chief Financial Officer | Buy(P) | 4K | $0.57 | $2K |
| Jun 1, 2022 | Cassirer Aurora | Director | Buy(P) | 2K | $0.69 | $1K |
| Dec 29, 2021 | Ferguson Michael | Director | Grant(A) | 58K | — | $0 |
| Dec 29, 2021 | Fashek Christopher M | Director | Grant(A) | 80K | — | $0 |
| Dec 29, 2021 | Mika Thomas | Director | Grant(A) | 60K | — | $0 |
| Dec 29, 2021 | Murphy Brian M | Chief Executive Officer, Director | Grant(A) | 300K | — | $0 |
| Dec 29, 2021 | Jacob Harold | Chief Medical Officer, Director | Grant(A) | 50K | — | $0 |
| Dec 29, 2021 | Goldstein Martin M | Director | Grant(A) | 50K | — | $0 |
| Dec 29, 2021 | Brown Stephen Russell | Chief Financial Officer | Grant(A) | 100K | — | $0 |
| Dec 22, 2020 | Mika Thomas | Director | Grant(A) | 90K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: ENvue Medical, Inc., SEC CIK 0001326706. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under FEED and shows every filing by that issuer (also filed as NAOV). Earlier filings under the same symbol by another issuer are left out.
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-12. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for FEED